Notice of Early Expiration of PAR-20-269 Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)
Notice Number:
NOT-AG-20-044

Key Dates

Release Date:

July 24, 2020

Related Announcements

PAR-20-269 - Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)

Issued by

National Institute on Aging (NIA)

Purpose

This Notice informs the extramural community of the early expiration of PAR-20-269 Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional). It will be re-issued immediately as an RFA.

Inquiries

Please direct all inquiries to:

Jean Yuan, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: yuanx4@mail.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices